BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32920643)

  • 1. Solute carrier family 12 member 2 as a proteomic and histological biomarker of dysplasia and neoplasia in ulcerative colitis.
    Merli AM; Vieujean S; Massot C; Blétard N; Quesada Calvo F; Baiwir D; Mazzucchelli G; Servais L; Wéra O; Oury C; de Leval L; Sempoux C; Manzini R; Bluemel S; Scharl M; Rogler G; De Pauw E; Coimbra Marques C; Colard A; Vijverman A; Delvenne P; Louis E; Meuwis MA
    J Crohns Colitis; 2020 Sep; ():. PubMed ID: 32920643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pattern of CD44 and matrix metalloproteinase 9 expression is a useful predictor of ulcerative colitis-associated dysplasia and neoplasia.
    AbdElazeem MA; El-Sayed M
    Ann Diagn Pathol; 2015 Dec; 19(6):369-74. PubMed ID: 26420348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
    Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
    J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STMN1 accumulation is associated with dysplastic and neoplastic lesions in patients with ulcerative colitis.
    Osone K; Yokobori T; Katayama C; Takahashi R; Kato R; Tatsuski H; Takada T; Yajima R; Motegi Y; Ogawa H; Fujii T; Ojima H; Nakamura J; Yao T; Shirabe K; Kuwano H
    Oncol Lett; 2019 Nov; 18(5):4712-4718. PubMed ID: 31611980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PHLDA1 expression in ulcerative colitis: A potential role in the management of dysplasia.
    Orita F; Ishikawa T; Ishiguro M; Okazaki S; Kikuchi A; Yamauchi S; Matsuyama T; Tokunaga M; Uetake H; Kinugasa Y
    Mol Clin Oncol; 2021 Sep; 15(3):192. PubMed ID: 34349991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer.
    Chen R; Pan S; Lai K; Lai LA; Crispin DA; Bronner MP; Brentnall TA
    World J Gastroenterol; 2014 Dec; 20(45):17037-48. PubMed ID: 25493016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating neoplastic progression of ulcerative colitis with label-free comparative proteomics.
    May D; Pan S; Crispin DA; Lai K; Bronner MP; Hogan J; Hockenbery DM; McIntosh M; Brentnall TA; Chen R
    J Proteome Res; 2011 Jan; 10(1):200-9. PubMed ID: 20828217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular profiling of ulcerative colitis-associated neoplastic progression.
    Colliver DW; Crawford NP; Eichenberger MR; Zacharius W; Petras RE; Stromberg AJ; Galandiuk S
    Exp Mol Pathol; 2006 Feb; 80(1):1-10. PubMed ID: 16277983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
    Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
    Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The miR-200 family is increased in dysplastic lesions in ulcerative colitis patients.
    Lewis A; Felice C; Kumagai T; Lai C; Singh K; Jeffery RR; Feakins R; Giannoulatou E; Armuzzi A; Jawad N; Lindsay JO; Silver A
    PLoS One; 2017; 12(3):e0173664. PubMed ID: 28288169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pit pattern analysis with high-definition chromoendoscopy and narrow-band imaging for optical diagnosis of dysplasia in patients with ulcerative colitis.
    Bisschops R; Bessissow T; Dekker E; East JE; Para-Blanco A; Ragunath K; Bhandari P; Rutter M; Schoon E; Wilson A; John JM; Van Steen K; Baert F; Ferrante M
    Gastrointest Endosc; 2017 Dec; 86(6):1100-1106.e1. PubMed ID: 28986266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in the clinical characteristic and prognosis of colitis-associated cancer and sporadic neoplasia in ulcerative colitis patients.
    Mutaguchi M; Naganuma M; Sugimoto S; Fukuda T; Nanki K; Mizuno S; Hosoe N; Shimoda M; Ogata H; Iwao Y; Kanai T
    Dig Liver Dis; 2019 Sep; 51(9):1257-1264. PubMed ID: 31151895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IBD-Associated Dysplastic Lesions Show More Chromosomal Instability Than Sporadic Adenomas.
    Wanders LK; Cordes M; Voorham Q; Sie D; de Vries SD; d'Haens GRAM; de Boer NKH; Ylstra B; van Grieken NCT; Meijer GA; Dekker E; Carvalho B
    Inflamm Bowel Dis; 2020 Jan; 26(2):167-180. PubMed ID: 31372648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinction between dysplasia-associated lesion or mass (DALM) and adenoma in patients with ulcerative colitis.
    Fogt F; Urbanski SJ; Sanders ME; Furth EE; Zimmerman RL; Deren JJ; Noffsinger AE; Vortmeyer AO; Hartmann CJ; Odze RL; Brown CA
    Hum Pathol; 2000 Mar; 31(3):288-91. PubMed ID: 10746669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of proinflammatory enzyme COX-2 and p53 in ulcerative colitis and its associated dysplasia and colorectal carcinoma.
    Elmashad NM; Ziada DH; Hasby EA; Mohamed AEM
    J Microsc Ultrastruct; 2016; 4(4):195-202. PubMed ID: 30023227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can dysplasia surveillance be better targeted in ulcerative colitis by using faecal calprotectin?
    Puolanne AM; Qadri S; Vesterinen T; Hiltunen S; Mustonen A; Kurki S; Kolho KL; Arola J; Färkkilä M
    Scand J Gastroenterol; 2022 Nov; 57(11):1304-1311. PubMed ID: 35697499
    [No Abstract]   [Full Text] [Related]  

  • 18. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
    Fujii S; Fujimori T; Chiba T
    J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional analysis of left-sided colitis, pancolitis, and ulcerative colitis-associated dysplasia.
    Bjerrum JT; Nielsen OH; Riis LB; Pittet V; Mueller C; Rogler G; Olsen J
    Inflamm Bowel Dis; 2014 Dec; 20(12):2340-52. PubMed ID: 25358065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of sporadic adenomas and adenoma-like dysplasia in patients with ulcerative colitis undergoing polypectomy.
    Kisiel JB; Loftus EV; Harmsen WS; Zinsmeister AR; Sandborn WJ
    Inflamm Bowel Dis; 2012 Feb; 18(2):226-35. PubMed ID: 21416564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.